Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Case | CASE | Nov 13, 2024 | 15.60 | +1.96 |
Castellum | CAST | Nov 13, 2024 | 127.05 | -1.09 |
Catella A | CATA | Nov 13, 2024 | 28.60 | +0.70 |
Catella B | CATB | Nov 13, 2024 | 28.85 | +0.52 |
Catena | CATE | Nov 13, 2024 | 495.50 | -0.50 |
Catena Media | CTM | Nov 13, 2024 | 4.20 | -3.34 |
Cavendish Hydrogen | CAVENO | Nov 13, 2024 | 11.00 | 0.00 |
Cavotec SA | CCC | Nov 13, 2024 | 16.75 | -1.76 |
CDON | CDON | Nov 13, 2024 | 95.00 | 0.00 |
Cedergrenska | CEDER | Nov 13, 2024 | 27.00 | 0.00 |
Cell Impact | CI | Nov 13, 2024 | 0.17 | -4.16 |
CellaVision | CEVI | Nov 13, 2024 | 239.00 | -1.44 |
Cereno Scientific B | CRNOB | Nov 13, 2024 | 4.91 | -0.61 |
ChargePanel AB (publ) | CHARGE | Nov 13, 2024 | 1.48 | -2.63 |
Checkin.com Group | CHECK | Nov 13, 2024 | 17.50 | +9.03 |
Cheffelo | CHEF | Nov 13, 2024 | 25.70 | -1.15 |
Chordate Medical Holding | CMH | Nov 13, 2024 | 22.30 | -0.45 |
Chosa Oncology AB | CHOSA | Nov 13, 2024 | 0.57 | -6.23 |
ChromoGenics | CHRO | Nov 13, 2024 | 9.78 | 0.00 |
Cibus Nordic Real Estate | CIBUS | Nov 13, 2024 | 170.25 | -0.55 |
Cinclus Pharma Holding AB | CINPHA | Nov 13, 2024 | 22.40 | +3.20 |
Cinis Fertilizer AB | CINIS | Nov 13, 2024 | 16.58 | 0.00 |
Cint Group | CINT | Nov 13, 2024 | 13.00 | +3.59 |
CirChem | CIRCHE | Nov 13, 2024 | 2.60 | -1.52 |
Circle Energy Sweden B | CIRCLEB | Nov 13, 2024 | 0.00 | +5.26 |
Clas Ohlson B | CLASB | Nov 13, 2024 | 190.00 | -1.20 |
Clavister Holding | CLAV | Nov 13, 2024 | 1.76 | -4.35 |
Clean Motion | CLEMO | Nov 13, 2024 | 0.41 | +7.37 |
Clemondo Group | CLEM | Nov 13, 2024 | 0.83 | +0.97 |
Climeon B | CLIMEB | Nov 13, 2024 | 0.35 | -8.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.